LUCIDRIL Film coated tablet Ref.[50998] Active ingredients: Meclofenoxate

Source: Web Search  Publisher: Manufactured by: Minapharm Co. for, Pharmaceuticals & Chemical Industries Minapharm Egypt

4.1. Therapeutic indications

Cerebral Aging, Cerebral atherosclerosis, neurological or psychological sequelea of head injury; manifesting by: mental deterioration; mental fatigue & inability to concentrate, disturbed memory and mood, intellectual impairment and behavioral changes. Neurological symptoms; Transient neurological attacks, paresis of face and limbs, Visual disturbance, Vertigo & tinnitus, Motor & sensory aphasia.

4.2. Posology and method of administration

2 tablets in the morning, 2 tablets at noon (before 4 O’clock p.m.) in repeated courses, not less than one month.

The degree of action of Lucidril is very largely dependent upon the duration of treatment.

6.4. Special precautions for storage

Lucidril should be stored at temperature not exceeding 30ยบC.

6.5. Nature and contents of container

Carton box of 20 tablets, each containing 250 mg of meclofenoxate hydrochloride.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.